Remove Blogging Remove Design Remove Research Remove San Diego
article thumbnail

Takeda Unites San Diego Operations At New ‘Biotech-Style’ R&D Center

Xconomy

That company was Syrrx, a private San Diego-based biotech that used X-ray crystallography to help determine the structures of disease-related molecules so drugs could be designed to target them. More than 90 percent of them are researchers. The site is one of three the company has worldwide: Its other research centers.

article thumbnail

Meet the Xconomy Awards San Diego Digital Trailblazer Finalists

Xconomy

San Diego’s prowess in computer science, medical devices, and life sciences makes it a natural hub of innovative digital health companies. This is part of a series of articles about the finalists for the Xconomy Awards San Diego. Here are brief profiles of the finalists.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

EY Names 6 Startup Leaders as San Diego Entrepreneurs of the Year

Xconomy

Six San Diego business risk-takers have been inducted into the pantheon of EY Entrepreneurs of the Year, joining over 10,000 people around the world who have been honored over the last 30 years by the multinational professional services firm. The winners are: — Life Sciences: BioLegend CEO Gene Lay.

article thumbnail

Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch

Xconomy

million from new investors, including the New York-based Juvenile Diabetes Research Foundation, following the results of a clinical study of its experimental biomarker monitoring device. Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC San Diego, started the company in 2012 as Electrozyme.

San Diego 103
article thumbnail

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

Xconomy

The Scripps Research Institute and AbbVie have agreed to broaden an existing drug discovery agreement focused on cancer cell therapies to now encompass treatments for other kinds of disease. Financial terms of this latest agreement weren’t disclosed, but the deal expands the purview. Read more » Reprints | Share:

article thumbnail

With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug

Xconomy

That research is starting to pay off as the companies now look ahead to pivotal studies testing that compound in several inherited forms of the disorder. The study was small and was not designed to show statistical significance. But combined with previously reported Phase 2 results in.

article thumbnail

Todd Hylton Adds Neural Tech Expertise to UCSD Robotics Institute

Xconomy

UC San Diego has named Todd Hylton, a veteran tech industry manager and expert in neural-based processing technology, as executive director of its new Contextual Robotics Institute. Hylton was previously the executive vice president of strategy and research at Brain Corp., After joining Brain Corp. At Brain Corp.,

UCSD 49